Background: Triple negative breast cancer (TNBC) lacks the benefit of a specific target therapy, so identification and evaluation of new therapeutic agents is a high priority. Enhancer of zeste homolog 2 (EZH2) is a putative stem cell marker involved in cell cycle regulation and was linked to aggressive breast cancer. Cytokeratin 5/6 (CK5/6) is a basal cytokeratin used to define basal like breast cancer. The aim: The aim of this work is to investigate the expression of enhancer of EZH2 and CK5/6 in triple negative in comparison with non-triple negative breast cancer using immunohistochemistry. Methods: EZH2 and CK5/6 were retrospectively analyzed by immunohistochemistry in 44 paraffin-embedded specimens of breast cancer patients (20 cases of triple negative and 24 of non-triple negative breast cancer). Results: TNBC was significantly associated with higher grade (p=0.001), high tumor budding (p=0.029), syncytial growth pattern (p=0.002), lymphovascular invasion (p=.0012), geographic necrosis (p=0.003) and lymphocytic infiltrate (p=.001). EZH2 expression is significantly associated with TNBC in comparison with non-TNBC (P=0.001). CK5/6 expression was observed in 75% of cases of TNBC in comparison to 30% of non-TNBC with a statistically significant relation between CK5/6 expression and TNBC (P=0.004). Among cases of TNBC, CK5/6 expression was significantly associated with lymph node metastasis and high tumor budding. Conclusion: Triple negative breast cancer has distinctive but not pathognomonic morphological features. EZH2 was highly expressed in TNBC in comparison with non-TNBC and this may explain the aggressiveness of triple negative breast cancer. Basal breast cancer, identified by CK5/6 expression, showed characteristic features in the form of high tumor budding, marked lymphocytic infiltrate and higher incidence of lymph node metastasis. This finding indicates that CK5/6 positive expression in TNBC is associated with poor prognostic characteristics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.